A New Rodent Model to Assess Blood Stage Immunity to the Plasmodium falciparum Antigen Merozoite Surface Protein 119 Reveals a Protective Role for Invasion Inhibitory Antibodies
Open Access
- 8 September 2003
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 198 (6), 869-875
- https://doi.org/10.1084/jem.20030085
Abstract
Antibodies capable of inhibiting the invasion of Plasmodium merozoites into erythrocytes are present in individuals that are clinically immune to the malaria parasite. Those targeting the 19-kD COOH-terminal domain of the major merozoite surface protein (MSP)-119 are a major component of this inhibitory activity. However, it has been difficult to assess the overall relevance of such antibodies to antiparasite immunity. Here we use an allelic replacement approach to generate a rodent malaria parasite (Plasmodium berghei) that expresses a human malaria (Plasmodium falciparum) form of MSP-119. We show that mice made semi-immune to this parasite line generate high levels of merozoite inhibitory antibodies that are specific for P. falciparum MSP-119. Importantly, protection from homologous blood stage challenge in these mice correlated with levels of P. falciparum MSP-119–specific inhibitory antibodies, but not with titres of total MSP-119–specific immunoglobulins. We conclude that merozoite inhibitory antibodies generated in response to infection can play a significant role in suppressing parasitemia in vivo. This study provides a strong impetus for the development of blood stage vaccines designed to generate invasion inhibitory antibodies and offers a new animal model to trial P. falciparum MSP-119 vaccines.Keywords
This publication has 22 references indexed in Scilit:
- Progress and challenges for malaria vaccinesNature, 2002
- Functional Equivalence of Structurally Distinct Ribosomes in the Malaria Parasite, Plasmodium bergheiPublished by Elsevier ,2001
- Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human AntibodiesThe Journal of Experimental Medicine, 1997
- The major merozoite surface protein as a malaria vaccine targetParasitology Today, 1993
- Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1Molecular and Biochemical Parasitology, 1992
- Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.The Journal of Experimental Medicine, 1990
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytesMolecular and Biochemical Parasitology, 1989
- Long-term in vitro cultures of Plasmodium berghei and preliminary observations on gametocytogenesisInternational Journal for Parasitology, 1984
- Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitroNature, 1982